The Connecticut House has approved requiring health insurance providers to cover biomarker testing, a process that involves using genome sequencing to diagnose disease more accurately.

In clinical trials, the accuracy of self-testing with Teal’s wand matched that of a cancer screening performed in a doctor’s office.

More than a quarter of the state's skilled nursing facilities could be impacted by a threatened strike by workers seeking ...